Mechanisms underlying neurocognitive dysfunctions in recurrent major depression

scientific article

Mechanisms underlying neurocognitive dysfunctions in recurrent major depression is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.12659/MSM.893176
P8608Fatcat IDrelease_xdxxkro6qnea7fxtw6pieeaprm
P3181OpenCitations bibliographic resource ID2184697
P932PMC publication ID4459569
P698PubMed publication ID26017336
P5875ResearchGate publication ID271518391

P50authorMichael MaesQ30504745
Michael BerkQ30504747
Monika TalarowskaQ91968916
Piotr GaleckiQ91968925
P2093author name stringGeorge Anderson
P2860cites workNitric oxide plasma concentration associated with cognitive impairment in patients with recurrent depressive disorderQ48745881
Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorderQ48786427
Cognitive control and brain resources in major depression: an fMRI study using the n-back taskQ48854842
Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolarQ48892798
Hippocampal volume and sensitivity to maternal aggressive behavior: a prospective study of adolescent depressive symptomsQ48924651
Auditory-verbal declarative and operating memory among patients suffering from depressive disorders - preliminary studyQ48946031
Functional polymorphism of the myeloperoxidase gene (G-463A) in depressive patientsQ49023250
Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems.Q50705251
[Correlations between working memory effectiveness and depression levels after pharmacological therapy].Q50731903
Updating the contents of working memory in depression: interference from irrelevant negative material.Q50872887
[Cognitive dysfunctions in bipolar disorders].Q50967737
Asymmetrical activation in the human brain during processing of fearful faces.Q50976462
The effect of psychiatric co-morbidity on cognitive functioning in a population-based sample of depressed young adults.Q51869759
Neurosteroids in the context of stress: implications for depressive disordersQ24646222
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathwaysQ26823313
Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadnessQ28143998
Association between a polymorphism in the pseudoautosomal X-linked gene SYBL1 and bipolar affective disorderQ28200777
Melatonin and its metabolites: new findings regarding their production and their radical scavenging actionsQ28292455
Sleep duration and depressive symptoms: a gene-environment interactionQ28394745
Significant modulation of mitochondrial electron transport system by nicotine in various rat brain regionsQ28580629
The protective role of Bax inhibitor-1 against chronic mild stress through the inhibition of monoamine oxidase AQ30558195
Neuropsychiatric symptoms in patients with aortic aneurysmsQ31028708
Mood disorders - review of structural MRI studiesQ31059298
Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorderQ31142879
Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary studyQ33291000
Depressive symptoms predict incident cognitive impairment in cognitive healthy older womenQ33726031
ASMT gene expression correlates with cognitive impairment in patients with recurrent depressive disorderQ33738683
Frontal and limbic activation during inhibitory control predicts treatment response in major depressive disorderQ33814969
fMRI BOLD responses to negative stimuli in the prefrontal cortex are dependent on levels of recent negative life stress in major depressive disorderQ34121855
Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogressionQ34405435
NF-κB drives the synthesis of melatonin in RAW 264.7 macrophages by inducing the transcription of the arylalkylamine-N-acetyltransferase (AA-NAT) geneQ34532746
Inflammation, depression and dementia: are they connected?Q34664224
Social stress in tree shrews: effects on physiology, brain function, and behavior of subordinate individualsQ34699510
Circadian rhythm disturbances in depressionQ34804250
Neuropsychological functioning in inpatients with major depression or schizophreniaQ34893185
Sex differences in the association between muscle quality, inflammatory markers, and cognitive declineQ35042613
[Cognitive functions and depression].Q51890966
Orbitofrontal cortex function and structure in depression.Q51899309
Low episodic memory performance as a premorbid marker of depression: evidence from a 3-year follow-up.Q51903729
The temporal relationship between depression symptoms and cognitive functioning in older medical patients--prospective or concurrent?Q51907876
Executive functions and updating of the contents of working memory in unipolar depression.Q51936909
Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.Q51938253
Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder.Q51943686
Cognitive and social functioning in recovery from depression: results from a population-based three-year follow-up.Q51981656
[Alzheimer's disease as neurodegenerative disorder].Q51982971
Identifying patients at high and low risk of cognitive decline using Rey Auditory Verbal Learning Test among middle-aged memory clinic outpatients.Q51984917
Cognitive function over the treatment course of depression in middle-aged patients: correlation with brain MRI signal hyperintensities.Q51995795
Time-related cognitive deficiency in four different types of depressionQ74493634
[Indicators of the persistent pro-inflammatory activation of the immune system in depression]Q79232305
Predictors of the Longitudinal Course of Major Depression in a Canadian Population SampleQ85236153
The inflammation hypothesis in geriatric depressionQ35177870
Acute exercise improves cognition in the depressed elderly: the effect of dual-tasksQ35188366
Misclassification and identification of emotional facial expressions in depressed youth: a preliminary studyQ35226492
Rumination and executive function in depression: an experimental studyQ35465859
Higher frontal EEG synchronization in young women with major depression: a marker for increased homeostatic sleep pressure?Q35529526
Depressive symptoms and cognitive decline in a community population of older persons.Q35560361
The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trialQ35753913
Sleep disturbances in Alzheimer's and Parkinson's diseasesQ35981780
Biomarkers for cognitive aging part II: oxidative stress, cognitive assessments, and medication adherenceQ36036672
Recent developments and current controversies in depressionQ36368849
Activity of human hippocampal and amygdala neurons during retrieval of declarative memoriesQ36423532
Amygdala and hippocampal volumes in familial early onset major depressive disorder.Q36499012
Cognitive dysfunction in elderly females with depressive symptomsQ36577600
I'm not crazy, I'm just depressed: differential diagnosis of dementia vs. depression.Q36656121
The cognitive neuropsychology of depression in the elderlyQ36870201
Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adultsQ36925067
The hippocampus and memory: insights from spatial processingQ37083215
Cortical thinning in persons at increased familial risk for major depressionQ37159052
Preparatory attention after lesions to the lateral or orbital prefrontal cortex--an event-related potentials study.Q37275900
Temporal relation between depression and cognitive impairment in old age: prospective population based studyQ37583024
Reduced cerebral perfusion predicts greater depressive symptoms and cognitive dysfunction at a 1-year follow-up in patients with heart failureQ37629514
Late-life depression, mild cognitive impairment, and dementia: possible continuum?Q37682019
Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?Q37812625
Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin.Q37813804
Reconceptualizing adult neurogenesis: role for sphingosine-1-phosphate and fibroblast growth factor-1 in co-ordinating astrocyte-neuronal precursor interactions.Q38138122
Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuinsQ38148491
Oxidative/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications.Q38158129
Cognitive symptoms in patients with major depressive disorder and their implications for clinical practiceQ38171893
Role of melatonin supplementation in neurodegenerative disordersQ38175730
The glutathione system: a new drug target in neuroimmune disordersQ38206126
Local melatonin regulates inflammation resolution: a common factor in neurodegenerative, psychiatric and systemic inflammatory disordersQ38228232
Multiple sclerosis: the role of melatonin and N-acetylserotonin.Q38383156
The effect of age and sex on clustering and switching during speeded verbal fluency tasksQ38383792
Perception of affective prosody in major depression: a link to executive functions?Q38389346
Neurocognition in depression: patients on and off medication versus healthy comparison subjectsQ38406779
Dissociable controlled retrieval and generalized selection mechanisms in ventrolateral prefrontal cortexQ38412655
Executive function improvement upon remission of recurrent unipolar depressionQ38416343
Abnormalities of the HPA axis in affective disorders: clinical subtypes and potential treatments.Q38779494
Apolipoprotein E influences melatonin biosynthesis by regulating NAT and MAOA expression in C6 cellsQ39416376
The relationship between the pineal gland and the pituitary-adrenal axis in health, endocrine and psychiatric conditionsQ40136380
Rumination and future thinking in depressionQ40507178
Activity-dependent depression of medial prefrontal cortex inputs to accumbens neurons by the basolateral amygdalaQ41012154
A single intraperitoneal injection of endotoxin in rats induces long-lasting modifications in behavior and brain protein levels of TNF-α and IL-18.Q42134649
Dissociating effects of subclinical anxiety and depression on cognitive controlQ42583201
Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's diseaseQ43242111
Effects of chronic stress on hippocampal long-term potentiationQ43986237
The impact of psychological variables on the presentation and progress of asthma and patient's cognitive functionsQ44097430
A distinct pattern of memory and attention deficiency in patients with depression.Q44103562
Selective attention in depression: influence of emotionality and personal relevanceQ44363014
Is left stroke a risk-factor for selective serotonin reuptake inhibitor antidepressant treatment resistance?Q44407277
Melatonin attenuates cognitive dysfunction and reduces neural oxidative stress induced by phosphamidonQ44739251
Clinical and neuropsychological comparison of psychotic depression with nonpsychotic depression and schizophrenia.Q45959268
Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.Q45987152
Melatonin improves learning and memory performances impaired by hyperhomocysteinemia in ratsQ46480944
Executive dysfunction and the course of geriatric depressionQ46600037
In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopesQ46624530
Cortisol level predicts executive and memory function in depression, symptom level predicts psychomotor speedQ46798224
Pineal melatonin and the innate immune response: the TNF-alpha increase after cesarean section suppresses nocturnal melatonin productionQ46970993
Brain activation measured with fMRI during a mental arithmetic task in schizophrenia and major depressionQ47228929
Discrepancy between self- and observer-rated depression severities as a predictor of vulnerability to suicide in patients with mild depressionQ47326763
Amygdala-function perturbations in healthy mid-adolescents with familial liability for depression.Q47887361
Maternal sleep deprivation inhibits hippocampal neurogenesis associated with inflammatory response in young offspring rats.Q48110759
Attenuated anterior cingulate activation during a verbal fluency task in elderly patients with a history of multiple-episode depressionQ48246670
Hydroxyindole O-methyltransferaseQ48248329
The perception of emotional chimeric faces in patients with depression, mania and unilateral brain damageQ48290885
Melatonin supplementation delays the decline of adult hippocampal neurogenesis during normal aging of miceQ48345612
Thiol protein groups correlate with cognitive impairment in patients with recurrent depressive disorderQ48353036
Attenuated left prefrontal activation during a verbal fluency task in patients with depressionQ48379030
Attenuated prefrontal activation during a verbal fluency task in remitted major depressionQ48545352
Total antioxidant status correlates with cognitive impairment in patients with recurrent depressive disorderQ48685612
P407language of work or nameEnglishQ1860
P921main subjectmemoryQ492
organic brain syndromeQ360341
neurogenesisQ1456827
major depressive disorderQ42844
physiological phenomenonQ66615932
P1104number of pages13
P304page(s)1535-1547
P577publication date2015-05-27
P1433published inMedical Science MonitorQ15756323
P1476titleMechanisms underlying neurocognitive dysfunctions in recurrent major depression
P478volume21

Reverse relations

cites work (P2860)
Q3980053210-year trajectories of depressive symptoms and risk of dementia: a population-based study
Q36146843Antidepressant-like effects of acupuncture involved the ERK signaling pathway in rats
Q38621902Autobiographical memory dysfunctions in depressive disorders.
Q28076540Characterizing neurocognitive impairment in young people with major depression: state, trait, or scar?
Q26768453Cognitive Dysfunction in Major Depressive Disorder. A Translational Review in Animal Models of the Disease
Q47913274Cognitive component of psychomotor retardation in unipolar and bipolar depression: Is verbal fluency a relevant marker? Impact of repetitive transcranial stimulation.
Q62722207Development of a Novel Staging Model for Affective Disorders Using Partial Least Squares Bootstrapping: Effects of Lipid-Associated Antioxidant Defenses and Neuro-Oxidative Stress
Q30235350Development of depression in survivors of childhood and adolescent cancer: a multi-level life course conceptual framework.
Q26750850Erythropoietin Pathway: A Potential Target for the Treatment of Depression
Q36833684Expression and Activity of Metalloproteinases in Depression.
Q54957550Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder.
Q91951161Marijuana use and major depressive disorder are additively associated with reduced verbal learning and altered cortical thickness
Q54980306Modulation of GSK-3β/β-Catenin Signaling Contributes to Learning and Memory Impairment in a Rat Model of Depression.
Q92897669Overview of Neurocognitive Disorders
Q60907580Oxidative Stress and the Microbiota-Gut-Brain Axis
Q92431590Recurrent stress across life may improve cognitive performance in individual rats, suggesting the induction of resilience
Q37636582Resveratrol counteracts lipopolysaccharide-induced depressive-like behaviors via enhanced hippocampal neurogenesis.
Q64105788Role of inflammation in depression relapse
Q33712117The Evolutionary Theory of Depression
Q48064458The role of MMP genes in recurrent depressive disorders and cognitive functions
Q60911552Transmembrane protein 108 involves in adult neurogenesis in the hippocampal dentate gyrus

Search more.